CROSBY Research – Pentamaster (1665 HK/BUY): Steady 2Q23 revenue growth, medical devices will drive 2H23 momentum

16 Aug 2023

Pentamaster’s 2Q23 revenue increased 16.8% YoY from MYR151.3m in 2Q22 to MYR176.8m. Automated Test Equipment (ATE) segment revenue surged 35.0% YoY to MYR148.5m on strong demand for EV product solutions. Factory Automation Solutions (FAS) segment revenue declined 31.5% YoY to MYR28.4m due to longer lead time and revenue recognition significantly varied quarter by quarter for this segment. GPM narrowed 1.1ppt YoY to 30.0% in 2Q23 on labor and inflationary pressure. Net profit was MYR37.6m in 2Q23, up 20.7% YoY.